The Use of Cloud and SaaS in the Drug and Device Development Lifecycle (Part 2)

Many pharmas have yet to get on board with cloud or SaaS. Here, we look at the biggest hurdle: the requirements of FDA validation.

As life sciences firms consider going to cloud or SaaS for applications to manage the content associated with drug and device development, it’s critical to account for how the necessary controls and tests will be applied in the provider’s data center to ensure FDA validation.



Rich Medina
Joe Shepley
I’m VP and Practice Lead, focusing on developing Doculabs’ InfoSec practice and its applications in a wide range of industries.